Incidence and Risk Factors of Ocular Hypertension and Glaucoma in Patients With Acanthamoeba Keratitis.

Adi Mohammed Al Owaifeer, Sarah Al-Omair, Shaimaa Alrefaie, Saad H Alenezi, Sami Al-Shahwan
{"title":"Incidence and Risk Factors of Ocular Hypertension and Glaucoma in Patients With Acanthamoeba Keratitis.","authors":"Adi Mohammed Al Owaifeer,&nbsp;Sarah Al-Omair,&nbsp;Shaimaa Alrefaie,&nbsp;Saad H Alenezi,&nbsp;Sami Al-Shahwan","doi":"10.1097/ICL.0000000000000824","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To determine the incidence of ocular hypertension (OHT) and glaucoma in patients with acanthamoeba keratitis (AK) and to outline the risk factors for the development of glaucoma.</p><p><strong>Methods: </strong>A retrospective review of patients diagnosed with AK at our institute during the period from 2000 to 2018. The main outcome measures were the incidence of OHT and glaucoma, and risk factors for the development of glaucoma.</p><p><strong>Results: </strong>Fifty-two eyes diagnosed with AK were included. The incidence of OHT and glaucoma was 51.9% and 32.7%, respectively. The mean duration from disease onset to the first attack of elevated intraocular pressure was 8.4±16.6 months. The use of corticosteroids in the treatment regimen was significantly associated with the development of glaucoma (odds ratio, 3.93; 95% confidence interval, 0.96-16.15; P=0.049). At the last follow-up visit, both patients with glaucoma and nonglaucoma patients had improved visual acuity without a difference in the mean amount of logarithm of the minimum angle of resolution acuity improvement among them (0.56±0.91 vs. 0.67±0.87, P=0.686).</p><p><strong>Conclusion: </strong>Our findings confirm that OHT and glaucoma are frequent complications in AK. Patients treated with a regimen containing corticosteroids are at a higher risk; thus, they should receive close intraocular pressure monitoring.</p>","PeriodicalId":502139,"journal":{"name":"Eye & Contact Lens","volume":" ","pages":"588-591"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye & Contact Lens","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ICL.0000000000000824","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Objectives: To determine the incidence of ocular hypertension (OHT) and glaucoma in patients with acanthamoeba keratitis (AK) and to outline the risk factors for the development of glaucoma.

Methods: A retrospective review of patients diagnosed with AK at our institute during the period from 2000 to 2018. The main outcome measures were the incidence of OHT and glaucoma, and risk factors for the development of glaucoma.

Results: Fifty-two eyes diagnosed with AK were included. The incidence of OHT and glaucoma was 51.9% and 32.7%, respectively. The mean duration from disease onset to the first attack of elevated intraocular pressure was 8.4±16.6 months. The use of corticosteroids in the treatment regimen was significantly associated with the development of glaucoma (odds ratio, 3.93; 95% confidence interval, 0.96-16.15; P=0.049). At the last follow-up visit, both patients with glaucoma and nonglaucoma patients had improved visual acuity without a difference in the mean amount of logarithm of the minimum angle of resolution acuity improvement among them (0.56±0.91 vs. 0.67±0.87, P=0.686).

Conclusion: Our findings confirm that OHT and glaucoma are frequent complications in AK. Patients treated with a regimen containing corticosteroids are at a higher risk; thus, they should receive close intraocular pressure monitoring.

棘阿米巴角膜炎患者高眼压和青光眼的发病率及危险因素。
目的:了解棘阿米巴角膜炎(AK)患者高眼压(OHT)和青光眼的发生率,并概述青光眼发生的危险因素。方法:对我院2000 - 2018年诊断为AK的患者进行回顾性分析。主要观察指标为OHT和青光眼的发生率,以及青光眼发生的危险因素。结果:52只眼被诊断为AK。OHT和青光眼的发生率分别为51.9%和32.7%。从发病到首次眼压升高的平均时间为8.4±16.6个月。在治疗方案中使用皮质类固醇与青光眼的发展显著相关(优势比,3.93;95%置信区间为0.96-16.15;P = 0.049)。最后一次随访时,青光眼患者和非青光眼患者的视力均有改善,两组患者的最小分辨视力改善角度的对数平均值无差异(0.56±0.91∶0.67±0.87,P=0.686)。结论:OHT和青光眼是AK的常见并发症。接受含皮质类固醇方案治疗的患者风险更高;因此,他们应该接受严密的眼压监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书